Pfizer reported positive Phase 2b results for its investigational ultra long acting GLP 1 receptor agonist, PF 3944, demonstrating continued weight loss after transitioning from weekly to monthly dosing, with no plateau observed at 28 weeks
Wegovy Injections Strengths available: Wegovy 0.25 mg pen delivers one 0.25 mg dose (0.25 mg/0.5 mL) Wegovy 0.5 mg pen delivers one 0.5 mg dose (0.5 mg / 0.5 mL) Wegovy 1 mg pen delivers one 1 mg dose (1 mg / 0.5 mL) Wegovy 1.7 mg pen delivers one 1.7 mg dose (1.7 mg / 0.75 mL) Wegovy 2.4 mg pen delivers one 2.4 mg dose (2.4 mg / 0.75 mL) Wegovy 7.2 mg pen delivers one 7.2 mg dose (7.2 mg/0.75 mL) Wegovy Tablets Dosing Information Initial dose: 1.5 mg once daily for 30 days
10.1111/obr.12436 42 RamboldA
"That broader availability though still limited may be what's driving GLP-1 usage higher overall." Related: Goldman Sachs doubles down on Novo stock target after key event This story was originally published by TheStreet on Jul 8, 2026, where it first appeared in the Health section
SCHEDULE A CONSULT OR SERVICE TODAY LINCOLN PARK Chicago, IL 60614 RIVER NORTH Chicago, IL 60654
This is where the newest generation of FDA-approved GLP-1 medications shine, helping to reset your bodys natural hunger cues
